F31 F32 F33 F34 F38 F39
Conditions
Interventions
Group 1: Subjects who receive a one-time examination by means of functional magnetic resonance imaging (MRI), including structural and resting perfusion MRI images as well as a blood sampling for gene
Sponsors
Bundesinstitut für Arzneimittel und Medizinprodukte
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: - Written consent to the study - Age restriction: 18-50 years - Healthy to shlightly reduced general condition (ASA 1-2) - BMI over 18 kg/m² - Good german language skills - Willingness and suitability for an MRI examination
Exclusion criteria
Exclusion criteria: - In women: Pregancy or breastfeeding period - Reduced general health condition - Regular drug ingestion (with the exception of Thyroxin (Euthyreose), Statins, ACE-Inhibitiors or oral contraceptives) - Metal implates (for example: pacemaker, copper spiral (in women), claustrophobia) - other contraindications for nuclear resonance imaging - consent incapable - Indication for neurological or psychatric diseases - No appropriate knowledge of german language to work on the questionnaires - not-to-know incidental findings
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of the present research project is to investigate the role of CYPs in healthy participants to the vulnerability to mental disorders through their action on endogenous substrates in the brain and their resulting effects on brain morphology and function. | — |
Countries
Germany
Contacts
Public ContactJulia Stingl
Bundesinstitut für Arzneimittel und Medizinprodukte
Outcome results
None listed